Literature DB >> 25646919

Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

Raphael Marlu1, J Barthelon2, A Durand2, N Mathieu2, C Barro1, V Granger2, A Tatu2, G Pernod3, B Polack1, B Bonaz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25646919     DOI： 10.1038/ajg.2014.391

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

1.  Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia.

Authors:  Brian T Brinkerhoff; David M Poetker; Nicholas W Choong
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

2.  Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Authors:  Sophie Dupuis-Girod; Isabelle Ginon; Jean-Christophe Saurin; Denis Marion; Elsa Guillot; Evelyne Decullier; Adeline Roux; Marie-France Carette; Brigitte Gilbert-Dussardier; Pierre-Yves Hatron; Pascal Lacombe; Bernard Lorcerie; Sophie Rivière; Romain Corre; Sophie Giraud; Sabine Bailly; Gilles Paintaud; David Ternant; Pierre-Jean Valette; Henri Plauchu; Frédéric Faure
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

3.  Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.

Authors:  Alexandru Lupu; Carmen Stefanescu; Xavier Treton; Alain Attar; Olivier Corcos; Yoram Bouhnik
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062

4.  A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias.

Authors:  Vrushali Dabak; Philip Kuriakose; Ginny Kamboj; Muhammad Shurafa
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

5.  Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.

Authors:  Patarapong Kamalaporn; Ramasamy Saravanan; Maria Cirocco; Gary May; Paul Kortan; Gabor Kandel; Norman Marcon
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566

6.  Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management.

Authors:  A Coppola; V De Stefano; A Tufano; G Nardone; A Amoriello; A M Cerbone; G Di Minno
Journal:  J Intern Med       Date:  2002-09       Impact factor: 8.989

7.  Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.

Authors:  G Cavaletti; A Beronio; L Reni; E Ghiglione; A Schenone; C Briani; G Zara; D Cocito; G Isoardo; P Ciaramitaro; R Plasmati; F Pastorelli; M Frigo; M Piatti; M Carpo
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

Review 8.  Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis.

Authors:  Christian S Jackson; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2014-03-18       Impact factor: 10.864
  8 in total
  3 in total

1.  Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome.

Authors:  Andrew B Song; Rahul Sakhuja; Nancy M Gracin; Ronald Weinger; Raj S Kasthuri; Hanny Al-Samkari
Journal:  Blood Adv       Date:  2021-10-12

2.  Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study.

Authors:  Robert Benamouzig; Mourad Benallaoua; Jean-Christophe Saurin; Marouane Boubaya; Christophe Cellier; René Laugier; Magalie Vincent; Christian Boustière; Rodica Gincul; Elia Samaha; Philippe Grandval; Thomas Aparicio; Gheorghe Airinei; Bakhtiar Bejou; Cyriaque Bon; Jean-Jacques Raynaud; Vincent Levy; Denis Sautereau
Journal:  Therap Adv Gastroenterol       Date:  2018-02-16       Impact factor: 4.409

3.  Glanzmann's thrombasthenia with spontaneous upper gastrointestinal bleeding: a case report.

Authors:  Zhenguo Qiao; Yi Chen; Wangtianyi Shi; Jun Yang; Yi Song; Jiaqing Shen
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.